NCT00441597View on ClinicalTrials.gov

Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Ischemia Reperfusion InjuryCardiovascular Disease
Interventions
DRUG

atorvastatin

atorvastatine 80mg, during 3 days

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT00441597 - Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo? | Biotech Hunter | Biotech Hunter